260 related articles for article (PubMed ID: 15067986)
1. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients].
Horváth B; Hegedüs D; Szapáry L; Márton Z; Alexy T; Koltai K; Gyevnár Z; Juricskay I; Tóth K; Késmárky G
Orv Hetil; 2003 Dec; 144(50):2471-6. PubMed ID: 15067986
[TBL] [Abstract][Full Text] [Related]
2. [Molecular markers of endothelial dysfunction in acute ischemic stroke].
Szegedi N; May Z; Ováry C; Skopál J; Nagy Z
Ideggyogy Sz; 2002 Mar; 55(3-4):102-8. PubMed ID: 12122979
[TBL] [Abstract][Full Text] [Related]
3. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
[TBL] [Abstract][Full Text] [Related]
4. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
Makin AJ; Blann AD; Chung NA; Silverman SH; Lip GY
Eur Heart J; 2004 Mar; 25(5):371-6. PubMed ID: 15033248
[TBL] [Abstract][Full Text] [Related]
5. Is interleukin-18 correlated with endothelial dysfunction and platelet activation in patients with unstable angina?
Jurcuţ R; Arsenescu I; Puşcariu T; Uscătescu V; Jurcuţ C; Apetrei E; Ginghină C
Rom J Intern Med; 2005; 43(3-4):199-209. PubMed ID: 16812980
[TBL] [Abstract][Full Text] [Related]
6. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
[TBL] [Abstract][Full Text] [Related]
7. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
Lee KW; Blann AD; Lip GY
Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
[TBL] [Abstract][Full Text] [Related]
8. vWf levels as a circulating marker of endothelial dysfunction in patients with hypertrophic cardiomyopathy.
Varol E; Ozaydin M; Sahin M; Altinbas A; Kosar F
Indian Heart J; 2005; 57(6):655-7. PubMed ID: 16521632
[TBL] [Abstract][Full Text] [Related]
9. [Von Willebrand factor in plasma of patients with age related macular degeneration].
Malukiewicz-Wiśniewska G; Rość D; Kałuzny B; Kałuzny JJ
Klin Oczna; 2005; 107(1-3):70-2. PubMed ID: 16052806
[TBL] [Abstract][Full Text] [Related]
10. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
Chan NN; Fuller JH; Rubens M; Colhoun HM
Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448
[TBL] [Abstract][Full Text] [Related]
11. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.
Apetrei E; Ciobanu-Jurcuţ R; Rugină M; Gavrilă A; Uscătescu V
Rom J Intern Med; 2004; 42(1):95-102. PubMed ID: 15529598
[TBL] [Abstract][Full Text] [Related]
13. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
14. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
[TBL] [Abstract][Full Text] [Related]
15. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
[TBL] [Abstract][Full Text] [Related]
16. [Endothelial cell activation and/or injury in multiple sclerosis: analysis with von Willebrand factor and thrombomodulin].
Kohriyama T; Maruyama H; Kurokawa K; Harada T; Nakamura S
Rinsho Shinkeigaku; 1997 Apr; 37(4):287-91. PubMed ID: 9248336
[TBL] [Abstract][Full Text] [Related]
17. Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction.
Jessani SS; Lane DA; Shantsila E; Watson T; Millane TA; Lip GY
Ann Med; 2009; 41(8):608-18. PubMed ID: 20021313
[TBL] [Abstract][Full Text] [Related]
18. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation.
Ferro D; Basili S; Lattuada A; Mantovani B; Bellomo A; Mannucci PM; Violi F
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):434-40. PubMed ID: 9494853
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of von Willebrand factor in subjects with isolated impaired fasting glucose.
Coban E; Bostan F
Med Sci Monit; 2009 Apr; 15(4):CR194-7. PubMed ID: 19333205
[TBL] [Abstract][Full Text] [Related]
20. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
